SEC Form 4 · accession 0001209191-17-060088
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan T Lord M.D.
Director
Period of report
Nov 8, 2017
Accepted (ET)
Nov 9, 2017 · 7:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.57 | Nov 8, 2017 | A | 19,737 | A | — | Nov 8, 2027 | Common Stock | 19,737 | 578,131 | D |
Explanation of responses
- F1The stock option vests and is exercisable in equal monthly installments over a consecutive 6-month period, commencing December 10, 2017.